This newsletter, the sixth since the ETERNAL project started, provides ample opportunities to dig deeper into both the project’s research illuminating the environmental risks surrounding pharmaceutical manufacture and positive responses from the industry to minimize the risks through technological innovation and standardization for less impactful, more efficient, sustainable and safe by design processes.
This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy.
By clicking Accept, you consent to our use of cookies.
